New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For BKS;JPM;WDC;NVS;GD;RDSA;MPC;VIA;AAPL;VIAB;BLK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 >>
January 26, 2016
06:45 EDTBLKBlackRock says clients seeking more illiquid holdings, Bloomberg says
Subscribe for More Information
06:11 EDTJPMJPMorgan reaches $1.42B settlement agreement in Lehman case, Bloomberg says
Subscribe for More Information
06:03 EDTAAPLVirnetX seeks $532M from Apple for alleged patent infringement, Bloomberg report
Subscribe for More Information
January 25, 2016
19:48 EDTAAPLApple design chief Jony Ive not unhappy with car project, CNET says
Subscribe for More Information
19:20 EDTAAPLApple reshuffles India operations after 'deep discounting' in quarter, ET says
Subscribe for More Information
16:00 EDTAAPLOptions Update; January 25, 2016
Subscribe for More Information
14:18 EDTAAPLApple volatility increases into Q1 and outlook
Subscribe for More Information
14:17 EDTAAPLVIX methodology for Apple VXAPL +3% to 39.17 into Q1 & outlook
Subscribe for More Information
14:06 EDTAAPLApple technical comments ahead of earnings, potential bearish pattern
There is a potential bearish head and shoulders top, which is most easily seen on a 3-year chart. The neckline for the pattern is at the $100 area on a closing basis, and in recent sessions the pattern has been both active and inactive as price crossed that line. If the news is bearish, a breakdown below $100 would see the pattern become active. Downside potential for the pattern would be to the $70 to $66 area. If the news is a bullish surprise, and sentiment has turned negative on the name which could add to short-cover demand, the counter-reaction up may be as large as pattern suggests is possible on the downside. It could mean in time a retaking of the $130 area or higher. The life high for the shares is at $134.54.
12:59 EDTAAPLApple executives unsatisfied with progress of 'Project Titan,' AppleInsider says
Subscribe for More Information
10:55 EDTNVSRegeneron slips after analyst says sell to avoid risk from Amgen patent suit
Shares of Regeneron Pharmaceuticals (REGN) fell in morning trading after an analyst at Chardan downgraded the stock to Sell, citing risk from a patent lawsuit in which the biopharmaceutical company is involved. CHARDAN SAYS SELL: Chardan Capital Markets analyst Gbola Amusa downgraded Regeneron to Sell from Neutral this morning, while reducing his price target on shares to $400 from $525. In a note to clients, Amusa said he believes that Regeneron is likely to face significant risks from the upcoming patent infringement case for Praluent. The suit could be a key driver of the company's share price performance in the near future, the analyst said. Regeneron, along with its partner Sanofi (SNY), launched Praluent in the U.S. last year, after the October 2014 filing of a patent infringement suit by Amgen (AMGN) relating to patents for "monoclonal antibodies that bind PCSK9," Amusa noted. The analyst believes that since Regeneron and Sanofi "likely" infringe Amgen's patents for Repatha, the Regeneron-Sanofi partnership could seek to settle the ahead of the trial by agreeing to pay 10%-20% or more of royalties to Amgen for U.S. Praluent sales. Amusa said that "such an outcome we estimate could transfer roughly $750M of operating income per year to Amgen." Further, Amusa said that catalysts surrounding the patent infringement trial are "likely to play out from late February to late March," and concedes that "both sides have good reasons to settle this case for a reasonable royalty." INCREASING COMPETITION: Amusa also noted that he sees increasing competitive risks in 2016 to Regeneron's Eylea from Novartis (NVS) and its partner Ophthotech (OPHT), which continue to progress Fovista into Phase III trials in wet AMD. WHAT'S NOTABLE: Roth Capital upgraded Regeneron to Buy from Neutral on January 19, based on valuation, as the firm said shares do not reflect the value of the company's upcoming catalysts. The firm also raised its price target to $555 from $543. The same day, Credit Suisse initiated Regeneron with a Neutral rating and $552 target. PRICE TARGET: Regeneron slipped 1.4% to $476.02 in morning trading.
10:03 EDTAAPLApple's iPhone 5se to likely come with faster A9/M9 chips, 9to5Mac reports
Subscribe for More Information
10:00 EDTJPMOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Eagle (AEO) downgraded to Hold from Buy at BB&T... American Express (AXP) downgraded on weak revenue outlook at Argus... Bristol-Myers (BMY) downgraded to Market Perform from Outperform at BMO Capital... Caterpillar (CAT) downgraded to Sell from Neutral at Goldman... Crestwood Equity (CEQP) downgraded to Neutral on potential distribution cut at Baird... Cummins (CMI) downgraded to Neutral from Buy at Citi... Federal Realty (FRT) downgraded to Hold from Buy at Evercore ISI... GKN PLC (GKNLY) downgraded to Neutral from Outperform at Credit Suisse... Galapagos NV (GLPG) downgraded to Neutral from Buy at GoldmanvHortonworks (HDP) downgraded to Perform from Outperform at Oppenheimer... International Flavors (IFF) downgraded on headwinds at Stifel... International Paper (IP) downgraded to Neutral from Buy at Citi... JPMorgan (JPM) downgraded to Neutral from Buy at Nomura... KapStone (KS) downgraded to Underperform from Neutral at Macquarie... Mosaic (MOS) downgraded to Neutral from Overweight at JPMorgan... NetSuite (N) downgraded to Equal Weight from Overweight at Stephens... ONEOK Partners (OKS) downgraded to Neutral at Baird... OvaScience (OVAS) downgraded to Perform from Outperform at Oppenheimer... Packaging Corp. (PKG) downgraded to Neutral from Buy at Citi... Potash (POT) downgraded to Neutral from Overweight at JPMorgan... Power Solutions (PSIX) downgraded to Neutral from Overweight at Piper Jaffray... Raymond James (RJF) downgraded to Neutral from Buy at Nomura... Regeneron (REGN) downgraded to Sell from Neutral at Chardan... SanDisk (SNDK) downgraded to Underperform from Outperform at CLSA... Toll Brothers (TOL) downgraded to Market Perform from Outperform at JMP Securities... Twitter (TWTR) downgraded to Hold from Buy at Stifel... WPX Energy (WPX) downgraded to Sector Perform from Outperform at Iberia... WestRock (WRK) downgraded to Neutral from Buy at BofA/Merrill... Whole Foods (WFM) downgraded to Underperform from Market Perform at BMO Capital... Zurich Insurance (ZURVY) downgraded to Neutral from Outperform at Exane BNP Paribas.
09:32 EDTAAPLApple Active equity options trading on open
Subscribe for More Information
08:11 EDTWDCWestern Digital acquires over a hundred patents from IBM
Western Digital (WDC) announced that it has acquired more than 100 patent assets from IBM (IBM). The parties also entered into a patent cross-license agreement. Terms of the transaction were not disclosed. Patents acquired by Western Digital are in distributed storage, object storage, and emerging non-volatile memory. Western Digital expects the IP to further strengthen its technology leadership position and drive value creation for the company and its customers. The patents will augment Western Digital's existing portfolio of more than 10,000 patents and patent applications.
07:10 EDTWDCWestern Digital pricing in 'extreme bear case,' says Jefferies
Subscribe for More Information
07:06 EDTAAPLApple volatility elevated into Q1 and outlook
Apple 1/29/16 call option implied volatility is at 57, February is at 38; compared to its 52-week range of 18 to 55, suggesting large near term price movement into the expected release of Q1 results on January 26.
07:03 EDTJPMJPMorgan downgraded to Neutral from Buy at Nomura
Subscribe for More Information
06:44 EDTAAPLApple to release new iPhone, iPad Air 3 in 1H16, AppleInsider says
Apple is planning to launch a 4-inch iPhone as well as the iPad Air 3 in the first half of the year, AppleInsider reports, citing KGI analyst Ming-Chi Kuo. Reference Link
05:51 EDTAAPLOptions expected to be active: TYC JCI TWTR SUNE AAPL PG HAL AMZN FB
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use